Replies to post #179228 on Biotech Values

[bellweather1]

Dew and jaybe,

Thanks for your feedback on at least a few of the many possible ways minority shareholders may "get screwed"(lol)...

Dew, I'll certainly take a closer look at your examples, although I don't think we're quit at the point where I have to worry about the company being(figuratively)sold for a song, just yet. But this certainly rounds out my appreciation of what to expect going forward.

jaybe,

Thanks for the feedback-I realize MW wears a lot of hats(either he's a great delegator, or has mastered the art of teleconferencing). But I've thought all along that although it would be possible for him to produce product when things get further along, he intends to either sell the co outright, or partner with some larger co that would take care of all those messy details.

From what I know of CNDO, I would guess that that's most likely the temporary gig(b/c nothing much seems to be happening there at the moment).

Thanks as well for the congrats, but since the gains are all virtual to date,in view of what both of us know all too well after our aria experience,I'm deferring any glee.

I'm just sorry Doug and I weren't able to persuade you and Dew to take a position here early on.

Best regards,

bw

[DewDiligence]

What’s left of GTC Biotherapeutics, a subsidiary of LFB Biotechnologies rechristened as rEVO Biologics, filed papers for an IPO:

https://www.sec.gov/Archives/edgar/data/904973/000119312514249319/d706707ds1.htm